Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +41.66%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +25.34%
#6 Walrus Walrus +23.68%
#7 Codatta Codatta +19.58%
#8 Enso Enso +18.19%
#9 The Black Bull The Black Bull +15.04%
#10 Collector Crypt Collector Crypt +14.18%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rang in Aktien #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Aktienkurs
$0.2488447
Zuletzt synchronisiert: 2024-10-01
Marktkapitalisierung
$2.01M
Veränderung (1 Tag)
-1.88%
Veränderung (1 Jahr)
0.00%
Land
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von Ortin Laboratories Limited (ORTINLAB)
Anzahl der ausstehenden Aktien zum June 2024: 8.13M
Laut den neuesten Finanzberichten und dem Aktienkurs von Ortin Laboratories Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 8.13M. Am Ende von March 2023 hatte das Unternehmen 8.13M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Ortin Laboratories Limited (ORTINLAB) von 2008 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 8.13M 0.01%
2024 8.13M -0.01%
2023 8.13M 0.00%
2022 8.13M -0.23%
2021 8.15M 0.24%
2020 8.13M 0.00%
2019 8.13M 0.00%
2018 8.13M 0.00%
2017 8.13M 0.00%
2016 8.13M -0.01%
2015 8.13M -0.04%
2014 8.14M -0.70%
2013 8.19M 0.23%
2012 8.17M 0.52%
2011 8.13M 361.54%
2010 1.76M 0.00%
2009 1.76M -0.01%
2008 1.76M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 29,407.06%
IN